Adeia

ADEA · NASDAQ

$21.30+$0.25 (+1.19%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $21.05

ADEA analyst rating

BuyConsensus of 4 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy4
Hold0
Underperform0
Sell0

12-month price target · 6 analysts

Average $43.86 (+105.9% upside)

Low: $39.39
Now: $21.30
High: $52.50

Upgrades and downgrades

The latest rating actions, newest first

ADEA analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
BWS Financial	Oct 7, 2026	Maintains	Buy	$50.00	56%
Rosenblatt	Sep 29, 2026	Maintains	Buy	$40.00	53%
BWS Financial	Aug 14, 2026	Maintains	Buy	$30.00 → $50.00	56%
BWS Financial	Aug 4, 2026	Maintains	Buy	$30.00	56%
Rosenblatt	Aug 4, 2026	Maintains	Buy	$40.00	53%
BWS Financial	May 5, 2026	Maintains	Buy	$30.00	56%
Rosenblatt	May 5, 2026	Maintains	Buy	$40.00	53%
Rosenblatt	Apr 2, 2026	Maintains	Buy	$40.00	53%
Roth Capital	Mar 16, 2026	Maintains	Buy	$27.00 → $34.00	48%
Rosenblatt	Mar 10, 2026	Maintains	Buy	$30.00 → $40.00	53%

The case for and against

Updated Oct 15, 2026

Bull case

Adeia is supported by a resilient IP licensing model, with renewal of Charter Communications’ Spectrum brand reducing litigation overhang and reinforcing the durability of its pay-TV cash flows. Its differentiated semiconductor portfolio is increasingly attractive as hybrid bonding adoption accelerates, while advanced thermal solutions for AI-driven semiconductors and new licensing frontiers expand the addressable opportunity and strengthen cross-portfolio benefits with media applications. With second quarter results showing accelerating adoption and management targeting $200 million in revenue, the company appears positioned for strong growth over the next several years under new CEO Dipti Vachani’s semiconductor expertise.

Bear case

Adeia is exposed to substantial execution risk because its growth depends on successful R&D outcomes, and its hybrid bonding technology and other innovations may never become commercially viable or widely adopted. The company’s sole IP licensing model also makes it vulnerable to patent challenges, invalidation, and infringement disputes, any of which could weaken monetization and reduce the value of its technology portfolio. As patents expire, Adeia faces greater competition and margin pressure, underscoring a fragile long-term earnings profile despite being valued on a 25x FY27 Non-GAAP EPS multiple.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.